iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
2B70ETF€7.54+1.17%Today
24h Range
€7.50€7.58
Market Overview
Total Assets€522.30M
Expense Ratio0.35%
52W High€7.60
52W Low€5.16
Technicals
50-Day MA€7.33
200-Day MA€6.86
Risk Metrics
1Y Volatility15.18%
3Y Volatility16.27%
Sharpe Ratio (3Y)0.50
Portfolio Allocation
US Stock93.9%
Non-US Stock5.9%
Cash0.2%
Recently Happened
Loading...
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
2B70ETF€7.54+1.17%Today
24h Range
€7.50€7.58
Market Overview
Total Assets€522.30M
Expense Ratio0.35%
52W High€7.60
52W Low€5.16
Technicals
50-Day MA€7.33
200-Day MA€6.86
Risk Metrics
1Y Volatility15.18%
3Y Volatility16.27%
Sharpe Ratio (3Y)0.50
Portfolio Allocation
US Stock93.9%
Non-US Stock5.9%
Cash0.2%
Recently Happened
Loading...
Performance
YTD
+5.24%
1Y
+52.04%
3Y
+13.15%
5Y
+5.60%
Portfolio Allocation
US Stock93.9%
Non-US Stock5.9%
Cash0.2%
Top 10 Holdings
10 holdings total1Amgen Inc
7.39%AMGN
2Gilead Sciences Inc
7.28%GILD
3Vertex Pharmaceuticals Inc
7.13%VRTX
4Regeneron Pharmaceuticals Inc
5.92%REGN
5Alnylam Pharmaceuticals Inc
3.31%ALNY
6Insmed Inc
2.37%INSM
7Revolution Medicines Inc
2.30%RVMD
8Biogen Inc
2.24%BIIB
9United Therapeutics Corporation
2.02%UTHR
10argenx NV ADR
1.78%ARGX
Top 10 Total41.74%
| # | Name | Ticker | Weight |
|---|---|---|---|
| 1 | Amgen Inc | AMGN | 7.39% |
| 2 | Gilead Sciences Inc | GILD | 7.28% |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 7.13% |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 5.92% |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | 3.31% |
| 6 | Insmed Inc | INSM | 2.37% |
| 7 | Revolution Medicines Inc | RVMD | 2.30% |
| 8 | Biogen Inc | BIIB | 2.24% |
| 9 | United Therapeutics Corporation | UTHR | 2.02% |
| 10 | argenx NV ADR | ARGX | 1.78% |
| Top 10 Total | 41.74% | ||
Performance
YTD
+5.24%
1Y
+52.04%
3Y
+13.15%
5Y
+5.60%
Portfolio Allocation
US Stock93.9%
Non-US Stock5.9%
Cash0.2%
Top 10 Holdings
10 holdings total1Amgen Inc
7.39%AMGN
2Gilead Sciences Inc
7.28%GILD
3Vertex Pharmaceuticals Inc
7.13%VRTX
4Regeneron Pharmaceuticals Inc
5.92%REGN
5Alnylam Pharmaceuticals Inc
3.31%ALNY
6Insmed Inc
2.37%INSM
7Revolution Medicines Inc
2.30%RVMD
8Biogen Inc
2.24%BIIB
9United Therapeutics Corporation
2.02%UTHR
10argenx NV ADR
1.78%ARGX
Top 10 Total41.74%
| # | Name | Ticker | Weight |
|---|---|---|---|
| 1 | Amgen Inc | AMGN | 7.39% |
| 2 | Gilead Sciences Inc | GILD | 7.28% |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 7.13% |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 5.92% |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | 3.31% |
| 6 | Insmed Inc | INSM | 2.37% |
| 7 | Revolution Medicines Inc | RVMD | 2.30% |
| 8 | Biogen Inc | BIIB | 2.24% |
| 9 | United Therapeutics Corporation | UTHR | 2.02% |
| 10 | argenx NV ADR | ARGX | 1.78% |
| Top 10 Total | 41.74% | ||
Technical Analysis
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap.
Trade iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)